Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

New HIV protease inhibitor JE-2147 with promising preclinical profile

Jan. 5, 1999

S-1153: preclinical and preliminary clinical results presented at AIDS congress

Jan. 5, 1999

NIH issues grant to Hughes Institute to further development of anti-HIV contraceptives

Jan. 5, 1999

Oligo- and polyribonucleotides with anti-HIV and anti-HCMV activity

Jan. 4, 1999

New research agreement to advance development of Medical Discoveries' novel AIDS drug

Jan. 4, 1999

New anti-HIV compound progresses in clinical studies at BMS

Jan. 4, 1999

Triangle initiates phase II/III testing of FTC in HIV and HBV infections

Jan. 4, 1999

Anti-HIV, antimalarial agents available for licensing from NIH

Dec. 30, 1998

Shaman achieves favorable phase III results with diarrhea treatment in AIDS patients

Dec. 28, 1998

FDA approves abacavir for treatment of HIV-1 infection

Dec. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...